NC
TMO icon

Noked Capital’s Thermo Fisher Scientific TMO Stock Holding History

Noked Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,050
Closed -$308K – 93
2019
Q2 		$308K Buy
+1,050
New +$289K 0.38% 44

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Noked Capital's TMO Position: Q3 2019 in Review

Noked Capital sold out of Thermo Fisher Scientific (TMO) in Q3 2019, closing a stake of 1,050 shares — an estimated $308K sold.

Noked Capital first reported a position in TMO in Q2 2019 and held it in 1 quarter. The position peaked at $308K in Q2 2019. 1,543 funds tracked by Wall St. Rank hold TMO as of Q3 2019.

  • Noked Capital reported no remaining Thermo Fisher Scientific position as of Q3 2019 after selling out during the quarter.
  • Noked Capital sold 1,050 Thermo Fisher Scientific shares in Q3 2019, an estimated $308K.
  • Noked Capital first reported a position in Thermo Fisher Scientific in Q2 2019 and held it in 1 quarter.
  • Noked Capital's Thermo Fisher Scientific position peaked at $308K in Q2 2019.
  • 1,543 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2019.

Based on Noked Capital's 13F filing for Q3 2019, filed 14 Nov 2019.